The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains

The clinical potential of mefloquine has been compromised by reports of adverse neurological effects. A series of 4-quinolinecarbinolamines were compared in terms of neurotoxicity and antimalarial activity in an attempt to identify replacement drugs. Neurotoxicity (MTT [thiazolyl blue reduction] ass...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Dow, Geoffrey S., Koenig, Michael L., Wolf, Lesley, Gerena, Lucia, Lopez-Sanchez, Miriam, Hudson, Thomas H., Bhattacharjee, Apurba K.
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2004
Assuntos:	Mechanisms of Action: Physiological Effects
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC434181/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15215119/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.7.2624-2632.2004
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!